In a bid to prioritise more human-relevant models, the US Food and Drug Administration (FDA) has enforced a plan to phase out animal testing for monoclonal antibodies (mAbs) in the preclinical stage, ...

Changing habits may be the hardest engineering challenge of all ...

New rule supports wider use of innovative testing methods while maintaining existing safety standards for human drug ...

With the FDA’s rule in place, sponsors now have clearer regulatory footing to submit nonclinical data generated through validated alternative methods as part of IND and marketing applications, though ...

A newly premiered documentary explores a growing question in biomedical research: Is animal testing still necessary, or can ...

Genoskin provides a unique alternative to animal testing by using excess human skin, donated by patients undergoing procedure. The skin is kept alive in testing wells and it is developed into a ...

Add Yahoo as a preferred source to see more of our stories on Google. This week, the Trump administration released new draft guidance meant to steer drugmakers toward alternatives to animal testing. - ...

As the Environmental Protection Agency (EPA) moves away from mammalian testing, it is pursuing alternatives for assessing ...

U.S FDA updated an 84 year old rule requiring animal testing before human trials by promoting use of alternatives like organoids, AI models for future drug testing.

Law360 (July 28, 2026, 2:01 PM EDT) -- Legislation advancing through Congress would force federal regulators to move more quickly to lift outdated animal testing requirements, experts say, providing ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...